These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 14535262)

  • 1. High-dose chemotherapy for breast cancer.
    Mangano MM
    N Engl J Med; 2003 Oct; 349(15):1476-9; author reply 1476-9. PubMed ID: 14535262
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved outcomes from dose-dense adjuvant chemotherapy for breast cancer with growth factor support.
    Leonard JP
    Curr Hematol Rep; 2003 Nov; 2(6):451-2. PubMed ID: 14561387
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dose chemotherapy for breast cancer.
    Wheatley K; Gray RG; Ives NJ
    N Engl J Med; 2003 Oct; 349(15):1476-9; author reply 1476-9. PubMed ID: 14534343
    [No Abstract]   [Full Text] [Related]  

  • 4. [High-dosage chemotherapy in breast cancer].
    Sola C; Ojeda B; Brunet J; López López JJ
    Med Clin (Barc); 1997 Mar; 108(10):398-9. PubMed ID: 9139151
    [No Abstract]   [Full Text] [Related]  

  • 5. [High-dose chemotherapy in carcinoma of the breast. Sunshine and shadows].
    Lelli G
    Recenti Prog Med; 2000 Dec; 91(12):647-9. PubMed ID: 11194485
    [No Abstract]   [Full Text] [Related]  

  • 6. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
    Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J;
    J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High dose chemotherapy versus conventional chemotherapy in metastasing breast cancer. An analysis of a systematic Cochrane review].
    Nielsen DL; Svane IM
    Ugeskr Laeger; 2004 Nov; 166(46):4145-7. PubMed ID: 15565848
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13.
    Peters WP; Rosner GL; Vredenburgh JJ; Shpall EJ; Crump M; Richardson PG; Schuster MW; Marks LB; Cirrincione C; Norton L; Henderson IC; Schilsky RL; Hurd DD
    J Clin Oncol; 2005 Apr; 23(10):2191-200. PubMed ID: 15767638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tamoxifen after chemotherapy in hormone receptor-positive, node-negative breast cancer.
    Panasci LC
    J Clin Oncol; 2006 May; 24(15):2392; author reply 2392. PubMed ID: 16710042
    [No Abstract]   [Full Text] [Related]  

  • 10. [High dose chemotherapy and stem cell transplant in patients with operable breast cancer and a poor prognosis; not indicated for the time being].
    Slee PH
    Ned Tijdschr Geneeskd; 2004 Jan; 148(1):9-12. PubMed ID: 14750448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy for lymph node-negative, estrogen receptor-negative breast cancer: a tale of three trials.
    Albain KS
    J Natl Cancer Inst; 2004 Dec; 96(24):1801-4. PubMed ID: 15601631
    [No Abstract]   [Full Text] [Related]  

  • 12. [The feasibility of FEC (75) as adjuvant chemotherapy for Japanese breast cancer patients].
    Kim SJ; Taguchi T; Miyoshi Y; Tanji Y; Tamaki Y; Noguchi S
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1919-23. PubMed ID: 16282727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer.
    Chen J; Wang L; Yao Q; Ling R; Li K; Wang H
    Breast Cancer Res; 2004; 6(4):R474-7. PubMed ID: 15217515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of breast metastasis of gastric cancer].
    Hasegawa S; Yoshikawa T; Yoshida T; Osaragi T; Cho H; Tsuburaya A; Kobayashi O; Sairenji M
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1115-8. PubMed ID: 17637552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of dose-dense chemotherapy in the management of breast cancer.
    Norton L
    Clin Adv Hematol Oncol; 2006 Jan; 4(1):36-7. PubMed ID: 16562368
    [No Abstract]   [Full Text] [Related]  

  • 16. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
    Jézéquel P; Campone M; Roché H; Gouraud W; Charbonnel C; Ricolleau G; Magrangeas F; Minvielle S; Genève J; Martin AL; Bataille R; Campion L
    Breast Cancer Res Treat; 2009 Aug; 116(3):509-20. PubMed ID: 19020972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can biology trump anatomy? Do all node-positive patients with breast cancer need chemotherapy?
    Henry NL; Hayes DF
    J Clin Oncol; 2007 Jun; 25(18):2501-3. PubMed ID: 17577024
    [No Abstract]   [Full Text] [Related]  

  • 18. Breast involvement in nodular lymphocyte predominant type Hodgkin lymphoma in childhood.
    Aksu G; Inan N; Corapcioglu F; Tugay M; Anik YA
    Pediatr Hematol Oncol; 2008 Mar; 25(2):159-61. PubMed ID: 18363184
    [No Abstract]   [Full Text] [Related]  

  • 19. Sentinel lymph node biopsy after neoadjuvant systemic chemotherapy in patients with breast cancer: a prospective pilot trial.
    Medina-Franco H; Salgado-Nesme N; Zerón-Medina-Cuairán J
    Rev Invest Clin; 2008; 60(5):390-4. PubMed ID: 19227436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End of high-dose chemotherapy for high-risk breast cancer patients?
    Tuma RS
    J Natl Cancer Inst; 2008 May; 100(9):618-9. PubMed ID: 18445811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.